Description
InformationPLX8394 is a next-generation, orally available, small-moleculeBRAFinhibitor with IC50 values of 3.8 nM, 14 nM and 23 nM for BRAF(V600E), WT BRAF and CRAF respectively. It has potential antineoplastic activity.TargetsBRAF(V600E) (Cell-free assay); BRAF (Cell-free assay); CRAF (Cell-free assay) 3.8 nM; 14 nM; 23 nMIn vitroPLX8394 is a next-generation, orally available small-molecule BRAFi that does not induce the RAF/MEK/ERK paradoxical activation and blocks signaling from both monomeric BRAFV600 and dimeric BRAFnon-V600 protein.Cell Research(from reference)Cell lines：colorectal cancer cell lines Concentrations：1 µM Incubation Time：6 h